DECA(Delisted)
Denali CapitalยทNASDAQ
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About DECA
Semnur Pharmaceuticals, Inc.
A Special Purpose Acquisition Company
437 Madison Avenue, 27th Floor, New York, New York 10022
--
Semnur Pharmaceuticals, Inc., incorporated in the Cayman Islands on January 5, 2022, changed to Delaware on 20250923. The purpose of the company is to carry out a merger, share capital transaction, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
Company Financials
EPS
DECA has released its 2022 Q2 earnings. EPS was reported at -1.64, versus the expected 0, missing expectations. The chart below visualizes how DECA has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
